Key Takeaways
- • Private equity ownership of hospices has surged dramatically: PE-backed hospices increased from 106 of 3,162 total facilities (3.4%) in 2011 to 409 of 5,615 (7.3%) by 2019, with acceleration continuing through 2022, fundamentally reshaping a traditionally nonprofit sector.
- • Everett hospice workers are raising concerns that private equity takeover will prioritize profit extraction over patient care quality, following a documented industry pattern where PE acquisition correlates with increased patient loads, reduced staffing, and adverse health outcomes.
- • Research indicates private equity's healthcare expansion produces measurable harm: studies demonstrate higher patient mortality rates, increased complications, and worse care experiences post-acquisition, while PE firms simultaneously increase debt burdens on acquired facilities to fund returns.
- • The hospice business model is particularly attractive to PE investors due to low barriers to entry, minimal capital requirements (most care delivered at-home with lower-cost workers), and predictable revenue streams, enabling rapid consolidation and quick-flip strategies.
- • Worker displacement and staffing reductions are common consequences of PE hospice acquisitions, with documented cases of nearly 800 job losses from facility closures, mirroring broader patterns seen across PE-owned healthcare services where cost-cutting strategies directly impact clinical capacity.
Summary
Hospice care in the United States has undergone a structural ownership transformation over the past 15 years, with private equity firms systematically acquiring a sector historically dominated by nonprofit organizations. According to analysis cited by KFF Health News, PE-backed hospice ownership grew from 106 facilities representing 3.4% of the market in 2011 to 409 facilities or 7.3% by 2019—a period during which 72% of PE acquisitions targeted nonprofit providers. This trajectory has accelerated further into 2022 and continues through 2026.
The Everett hospice case exemplifies worker and caregiver concerns now surfacing across the industry. Staff members are expressing alarm that private equity ownership will implement cost-reduction strategies documented in peer-reviewed research, including increased patient-to-caregiver ratios and reduced staffing levels. These concerns are grounded in empirical findings: multiple studies indicate that quality of care and patient outcomes measurably deteriorate following private equity acquisition of healthcare facilities. Research suggests PE-owned hospices correlate with higher patient mortality rates, increased complications, and diminished patient and family experiences during end-of-life care.
The financial appeal to PE investors is straightforward: hospice operates on a low-friction, high-margin business model. Most care occurs in patient homes rather than institutional settings, utilizing lower-cost health workers rather than expensive clinical staff. This structure enables PE firms to acquire multiple smaller hospices, consolidate administrative and supply-chain operations, and extract returns through economies of scale before selling consolidated chains to larger operators or subsequent PE buyers. The predictable revenue stream from government reimbursement (Medicare/Medicaid) further enhances investment thesis appeal.
However, this financial engineering model generates documented harms. Dr. Joan Teno, adjunct professor at Brown University School of Public Health and end-of-life care researcher, articulated the core concern: "Many of these transactions are driven by the motive of a quick profit...I'm very concerned that you're harming not only the dying patient, but the family whose memory will be of a loved one suffering because they didn't get adequate care." Beyond patient impact, PE consolidation has displaced healthcare workers—documented cases show nearly 800 job losses from facility closures—while increasing debt burdens on acquired facilities to fund investor returns.
The hospice sector's vulnerability to PE acquisition reflects broader dynamics in healthcare services acquisition, where profit-driven capital prioritizes short-term returns over care quality. Industry observers characterize this shift as fundamentally misaligned with hospice's original mission, which emphasized dignity, comfort, and family support during end-of-life care rather than margin optimization.
The Everett hospice case exemplifies worker and caregiver concerns now surfacing across the industry. Staff members are expressing alarm that private equity ownership will implement cost-reduction strategies documented in peer-reviewed research, including increased patient-to-caregiver ratios and reduced staffing levels. These concerns are grounded in empirical findings: multiple studies indicate that quality of care and patient outcomes measurably deteriorate following private equity acquisition of healthcare facilities. Research suggests PE-owned hospices correlate with higher patient mortality rates, increased complications, and diminished patient and family experiences during end-of-life care.
The financial appeal to PE investors is straightforward: hospice operates on a low-friction, high-margin business model. Most care occurs in patient homes rather than institutional settings, utilizing lower-cost health workers rather than expensive clinical staff. This structure enables PE firms to acquire multiple smaller hospices, consolidate administrative and supply-chain operations, and extract returns through economies of scale before selling consolidated chains to larger operators or subsequent PE buyers. The predictable revenue stream from government reimbursement (Medicare/Medicaid) further enhances investment thesis appeal.
However, this financial engineering model generates documented harms. Dr. Joan Teno, adjunct professor at Brown University School of Public Health and end-of-life care researcher, articulated the core concern: "Many of these transactions are driven by the motive of a quick profit...I'm very concerned that you're harming not only the dying patient, but the family whose memory will be of a loved one suffering because they didn't get adequate care." Beyond patient impact, PE consolidation has displaced healthcare workers—documented cases show nearly 800 job losses from facility closures—while increasing debt burdens on acquired facilities to fund investor returns.
The hospice sector's vulnerability to PE acquisition reflects broader dynamics in healthcare services acquisition, where profit-driven capital prioritizes short-term returns over care quality. Industry observers characterize this shift as fundamentally misaligned with hospice's original mission, which emphasized dignity, comfort, and family support during end-of-life care rather than margin optimization.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.